Atlas Trials

Efficacy of Ultrasound Contrast Agent to Assess Renal Masses

Clinical trial NCT01062178 · COMPLETED

Trial details

NCT number
NCT01062178
Sponsor
University Health Network, Toronto
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Renal Cell Carcinoma
Start date
2009-10-01
Primary completion
2012-10-01
Enrollment
167

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.